Novo Nordisk announces that CVS Caremark®, the country’s largest PBM, has decided Wegovy® will be the preferred GLP-1 medicine covered for obesity on its template formularies PR Newswire Nawigacja wpisu News – Navy Medicine Announces FY24 Sailor of the Year – DVIDS ULSOM tactical medicine interest group completes immersive training with LMPD – UofL
